adenine has been researched along with Abnormal Karyotype in 4 studies
Abnormal Karyotype: A variation from the normal set of chromosomes characteristic of a species.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kipps, TJ | 1 |
| Fraser, G | 1 |
| Coutre, SE | 1 |
| Brown, JR | 1 |
| Barrientos, JC | 1 |
| Barr, PM | 1 |
| Byrd, JC | 2 |
| O'Brien, SM | 2 |
| Dilhuydy, MS | 1 |
| Hillmen, P | 1 |
| Jaeger, U | 1 |
| Moreno, C | 1 |
| Cramer, P | 1 |
| Stilgenbauer, S | 1 |
| Chanan-Khan, AA | 1 |
| Mahler, M | 1 |
| Salman, M | 1 |
| Eckert, K | 1 |
| Solman, IG | 1 |
| Balasubramanian, S | 1 |
| Cheng, M | 1 |
| Londhe, A | 1 |
| Ninomoto, J | 1 |
| Howes, A | 1 |
| James, DF | 1 |
| Hallek, M | 1 |
| Scapinello, G | 1 |
| Riva, M | 1 |
| Branca, A | 1 |
| Pizzi, M | 1 |
| Bonaldi, L | 1 |
| Martines, A | 1 |
| Manni, S | 1 |
| Visentin, A | 1 |
| Trentin, L | 1 |
| Semenzato, G | 1 |
| Gurrieri, C | 1 |
| Piazza, F | 1 |
| Kittai, AS | 1 |
| Miller, C | 1 |
| Goldstein, D | 1 |
| Huang, Y | 1 |
| Abruzzo, LV | 1 |
| Beckwith, K | 1 |
| Bhat, SA | 1 |
| Bond, DA | 1 |
| Grever, MR | 1 |
| Heerema, NA | 1 |
| Rogers, KA | 1 |
| Ruppert, AS | 1 |
| Woyach, JA | 1 |
| Thompson, PA | 1 |
| Wierda, WG | 1 |
| Ferrajoli, A | 1 |
| Stingo, F | 1 |
| Smith, SC | 1 |
| Burger, JA | 1 |
| Estrov, Z | 1 |
| Jain, N | 1 |
| Kantarjian, HM | 1 |
| Keating, MJ | 1 |
4 other studies available for adenine and Abnormal Karyotype
| Article | Year |
|---|---|
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
Topics: Abnormal Karyotype; Adenine; Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 11 | 2019 |
A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.
Topics: Abnormal Karyotype; Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydr | 2020 |
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.
Topics: Abnormal Karyotype; Adenine; Adult; Aged; Aged, 80 and over; Clonal Evolution; Female; Humans; Leuke | 2021 |
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens.
Topics: Abnormal Karyotype; Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Delet | 2015 |